SOL SpA
MIL:SOL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (31.1), the stock would be worth €44.07 (23% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 40.7 | €57.6 |
0%
|
| 3-Year Average | 31.1 | €44.07 |
-23%
|
| 5-Year Average | 31.1 | €44.07 |
-23%
|
| Industry Average | 95.1 | €134.6 |
+134%
|
| Country Average | 19.4 | €27.47 |
-52%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
SOL SpA
MIL:SOL
|
5.2B EUR | 40.7 | 31.5 | |
| UK |
L
|
Linde PLC
XETRA:LIN
|
201.3B EUR | 29 | 33.6 | |
| FR |
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
PAR:AI
|
105.8B EUR | 24.4 | 30.1 | |
| US |
|
Air Products and Chemicals Inc
NYSE:APD
|
66.8B USD | 127 | -200.2 | |
| JP |
|
Nippon Sanso Holdings Corp
TSE:4091
|
2.4T JPY | 31.2 | 20.9 | |
| IN |
|
Linde India Ltd
NSE:LINDEINDIA
|
624.3B INR | -75.4 | 106.2 | |
| CN |
P
|
Peric Special Gases Co Ltd
SSE:688146
|
42.5B CNY | 617.7 | 134.8 | |
| CN |
|
Hangzhou Oxygen Plant Group Co Ltd
SZSE:002430
|
30.7B CNY | 32.9 | 32.5 | |
| CN |
G
|
Guangdong Huate Gas Co Ltd
SSE:688268
|
22.6B CNY | 498.6 | 122.7 | |
| CN |
S
|
Sichuan Qiaoyuan Gas Co Ltd
SZSE:301286
|
20.3B CNY | 162.4 | 100.8 | |
| JP |
|
Air Water Inc
TSE:4088
|
434.5B JPY | 30.5 | 56.1 |
Market Distribution
| Min | 0.9 |
| 30th Percentile | 11.9 |
| Median | 19.4 |
| 70th Percentile | 28.4 |
| Max | 10 354.4 |
Other Multiples
SOL SpA
Glance View
In the bustling industrial landscape of Italy, SOL SpA has carved its niche as a pivotal player in the realm of industrial gas and healthcare services. Established in 1927, the company has a rich legacy of innovation and adaptation, supplying essential gases like oxygen, nitrogen, and argon to a variety of industries—ranging from metalwork and electronics to food and beverage. Over the years, SOL expanded its horizons beyond the traditional industrial sector, entering into the healthcare market with a focus on homecare services. This diversification not only amplified its market reach but also cushioned its revenues against the cyclicality typically associated with industrial sectors. SOL SpA's financial success hinges on its dual operating strategy: producing and distributing industrial gases while providing critical healthcare services. In the gases segment, the company boasts a network of advanced production facilities and a sophisticated logistics system, enabling the efficient distribution of these gases across Europe and beyond. Meanwhile, the healthcare segment, which includes home respiratory therapies and medical equipment supplies, ensures a steady stream of income by tapping into the ever-growing demand for at-home medical care. This balanced portfolio allows SOL SpA to maintain a robust revenue stream, harnessing the stability of the healthcare sector while continuing to innovate and serve the dynamic industrial landscape.